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SumlTlary 
Immunoglobulin (Ig) class switching in B cells is regulated by stimuli transduced by cytokines and 
cell-cell contact. Among these stimuli, interleukin (IL)-4 has been considered an absolute prerequi- 
site for class switching to IgE in the mouse. Here we report that IL-4-deficient (IL-4 -/-) and wild- 
type mice had comparably elevated serum IgE levels during the course of a murine retrovirus- 
induced  immunodeficiency  syndrome,  MAIDS.  IgE  switching in  IL-4  -/-  mice was  also  in- 
duced by injection  of anti-IgD  antibody.  Treatment with anti-IgD  induced  germline epsilon 
(g~) transcripts with comparable efficiency in IL-4 -/- mice and controls, but the levels of pro- 
ductive epsilon transcripts  (pc)  were lower by a factor of 200 and serum IgE levels were lower 
by a factor of 300 in IL-4 -/-  mice as compared with controls.  Induction  of g~ after anti-IgD 
treatment  of IL-4 -/-  mice was  unaffected  by simultaneous  treatment with  monoclonal  anti- 
bodies to IL-4 and IL-4 receptor e~ chain. Infection of lL-4 -/- mice with Nippostrongylus brasil- 
iensis, a potent stimulus for IgE production,  resulted in induction of g~ transcripts; however, p~ 
transcripts  were barely detectable  and serum  IgE was not  detected.  These findings  establish a 
novel IL-4--independent  pathway for IgE switching in the mouse that is strongly activated in 
retroviral infection but weakly in nematode infection.  This pathway appears to be dependent 
on distinct factors that separately control induction  of ge transcription and switch recombina- 
tion to pc. 
I  g  class  switching  during  an  immune  response  is  con- 
trolled by cytokines and cognate interactions between T 
and B  cells.  For example, IL-4 in conjunction with CD40- 
CD40L  interactions  directs  class switching  to  both  IgG1 
and  igE  in  the  mouse  (1,  2).  In vitro  studies  have  shown 
that  cytokines  regulate  germline  hea  W  chain  constant  re- 
gion (Crt) 1 transcription,  which is believed to target switch 
recombination to specific heavy chain isotypes (3, 4). In the 
mouse, IL-4 stimulates induction of g'yl and germline epsi- 
1Abbreviations used in  this paper: CH, heavy chain constant region; DC- 
PCP,., digestion-circularization PCP.; GaMIS, goat anti-mouse lgD; ge, 
germline epsilon; HPRT, hypoxanthine phosphoribosyl transferase; MAIDS, 
routine acquired immunodeficiency syndrome; MuLV, routine leukemia 
virus; pe, productive epsilon; RT-PCR, reverse-transcription PCP.. 
lon  (g~) transcripts,  IFN-~/  stimulates  increased  levels  of 
gy2a and gy3  transcripts,  and TGF-I3 stimulates increased 
levels of g3¢2b and gel transcripts.  The induction of distinct 
germline transcripts by different cytokines is reflected in the 
prevailing serum lg isotypes during immune responses asso- 
ciated  with  either  type  1  or  type  2  cytokine  production. 
Infections  eliciting  a  dominant  humoral  response  feature 
high-level expression of type 2 cytokines and are associated 
with  elevated  serum  IgE  and  IgG1.  Delayed-type  hyper- 
sensitivity  responses exhibit  high  IFN-y  and  IL-2  expres- 
sion and are associated with high levels of serum IgG2a (for 
review, see reference 5). 
It has  been  shown  in  vitro  and  in  one  in  vivo  experi- 
mental system (injection of goat anti-mouse  IgD  [GaMS]) 
that the switch to IgE in mice is strictly dependent on IL-4, 
with  IL-4 being required  to  induce  increased  levels  of g~ 
transcripts (6-8).  Inhibition of increases in ge transcripts by 
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tive epsilon  (pc)  transcripts and  secretion of IgE  during a 
primary immune response (9, 10). Moreover, mice in which 
the IL-4 gene has been inactivated by targeted gene disrup- 
tion  failed to  produce  serum  IgE  after infection with  the 
nematode Nippostrongylus  brasiliensis (11,  12). 
During  our  studies  of a  murine  acquired immunodefi- 
ciency syndrome  (MAIDS), we  found  that  mice  deficient 
for IL-4 and their control littermates produced high levels 
of serum IgE in response to this retrovirus infection. MAIDS 
is  characterized by increasingly severe immunodeficiency, 
progressive lymphoproliferation, and hypergammaglobuline- 
rnia that  develops after infection of susceptible mice  with 
the LP-BM5 mixture of murine leukemia viruses (MuLVs) 
(13,  14). 
To determine whether the phenomenon  of IgE switch- 
ing  in  the  absence  of IL-4  was  restricted  to  mice  with 
MAIDS, we took advantage of two well-characterized sys- 
tems  known  to  induce  efficient switching to  IgE  in vivo: 
treatment  of mice  with  GaM8  antiserum,  and  infection 
with N.  brasiliensis. In this paper, we report that IL-4 is not 
required  for induction  of ge  transcripts in  either  of these 
systems  and  that  IL-4-deficient  mice  produced  g~  tran- 
scripts at levels comparable to those of controls after treat- 
ment with GaM& however, germline transcription ofe did 
not necessarily lead to  switch recombination at this locus. 
Thus, even though IL-4  /- mice infected with N.  brasilien- 
sis  produced ge  transcripts,  they generated  only very low 
levels of pc transcripts and failed to switch to IgE. IL-4  -/- 
mice treated with anti-IgD, however, did switch to pe and 
produced serum  IgE,  but much  less than  wild-type mice. 
Only upon retroviral infection were serum IgE levels in the 
IL-4  -/  mice comparable to those found in controls. These 
findings  establish  a  novel  IL-4-independent  pathway  for 
IgE  switching in  the  mouse,  with possibly distinct factors 
controlling  transcriptional  activation,  switch  recombina- 
tion, and secretion of IgE. 
Materials  and Methods 
Mice and  Viruses.  129/01a  IL-4  -/-  (11) were backcrossed to 
C57BL/6J  (B6)  for  12  generations  (C57BL/6-IL-4tmlCg  ~]29  = 
B6.1L_4-/  129). Genetically pure B6 IL-4  /- mice (C57BL/6-IL- 
4 trnlnnt =  B6.IL-4  /  B6; Noben-Trauth, N., manuscript in prepa- 
ration)  were  generated from the B6  embryonic stem cell line 
B6-III (15).  B6 and BALB/c female mice were purchased from 
the Small Animals Division of the National Cancer Institute (Fre- 
derick, MD) or from The Jackson Laboratory (Bar Harbor, ME) 
and were used at 8-12 wk of age. 
Mice were inoculated intraperitoneally with 0.1 ml of LP-BM5 
MuLV virus pools at 6-8 wk of age. Virus stocks were prepared 
from the G6 clone of chronically infected SC-1 cells as described 
previously (16). These stocks contain a mixture ofnonpathogenic 
ecotropic and  mink  cell focus-inducing MuLV  and  a  disease- 
causing defective genome. At selected times after infection, mice 
were  killed and  bled;  serum  was  stored  at  -20°C  until  use. 
Spleen  weight,  degree  of lymphadenopathy,  histopathological 
evaluations of selected tissues obtained at autopsy, FACS  ® profiles 
of splenic cell populations, and in vitro proliferative responses and 
cytokine production to B and T  cell mitogens were used to stage 
the progression of MAIDS by criteria detailed previously (17-19). 
Antibodies.  Neutralizing mAbs for mouse IL-4 (11Bll)  (20), 
GaM8 (21), and rat anti-mouse IL-4R c~ chain (M1)  (22) were as 
described previously, mAb  GLl17  (anti-Escherichia  coli [3-galac- 
tosidase) was used as an isotype control for treatment with M1. 
Stimulation of lgE Responses In Vivo.  Primary IgE responses were 
induced by injecting mice subcutaneously with a previously de- 
termined optimal dose  of GaM8  antiserum.  Antibodies against 
IL-4 and IL-4R0~ chain were injected intraperitoneally 24 h be- 
fore treatment with GaM8 antiserum. 
Infection of Mice with N. brasiliensis.  Normal  B6,  B6.IL-4  /-129, 
and B6.IL-4  +/  129 were infected with 500 larvae ofN. brasiliensis 
as previously described (5).  Some mice were treated with anti- 
IFN-y mAb (XGM1.2; 2 mg/wk) or anti-IL-4 mAb (5 mg/wk) 
at the time of infection. Animals were bled at 14 and 21  d after 
infection for determinations of serum IgE levels. Secondary chal- 
lenges with N. brasiliensis were given at 3 wk after the primary in- 
fection and treatments with anticytokine antibodies were contin- 
ued. IgE levels were determined in sera obtained at 14 and 21  d 
after secondary infection. 
Measurement of Polydonat Serum IgE and IgG1 Levels.  Serum IgE 
concentrations were measured by ELISA as described previously 
(23).  Briefly,  96-well  microtiter  plates  (CoStar  Corp.,  Cam- 
bridge, MA) were coated with a mixture (1 I~g/ml of each) of the 
02131D  anti-IgE antibody (PharMingen,  La Jolla, CA)  and the 
LO-ME  anti-IgE  antibody  (BioSource,  Camarillo,  CA).  After 
blocking the plates with BSA and overnight incubation with the 
samples,  the plates were developed using horseradish peroxidase- 
conjugated goat anti-IgE antibodies (Southern Biotechnology As- 
sociates,  Inc.,  Birmingham,  AL).  Plates  were  developed  with 
ABTS peroxidase substrate  (Kirkegaard and Perry Laboratories, 
Inc., Gaithersburg, MD). 
IgG1  titers were  determined  similarly using  the  appropriate 
coating and developing antibodies from Southern Biotechnology 
Associates, Inc.  All ELISA incubations were performed in  10% 
FCS/PBS. 
IgE titers in the sera of LP-BM5 MuLV-infected mice were 
verified in two other independent ELISA assays for lgE used at 
DNAX Research Institute of Molecular and Cellular Biology and 
in University of Cologne, respectively. To be able to compare IgE 
data from the different experimental systems described in this paper, 
titers determined at the National Institutes of Health are reported for 
all experiments except those involving infection with N. brasiliensis. 
PGE  2.  Suspensions of cells prepared from spleens of mice in- 
jected with LP-BM5 MuLV or with GaM8 were stimulated in 
vitro with LPS (20 txg/ml E. coli 0127-B8; L-4516; Sigma Chemi- 
cal Co., St. Louis, MO). Culture superuatants harvested after 24 h 
were analyzed for PGE 2 by radioimmunoassay as described previ- 
ously (24). 
RNA  Purification and cDNA  Synthesis.  Mouse  spleen  samples 
(40  mg) were stored at  -70°C  in RNazol  (TEL-Test,  Friends- 
wood, TX) until further processing. RNA was extracted accord- 
ing to the manufacturer's directions. 1 I~g RNA was reverse tran- 
scribed using MuLV reverse transcriptase (Promega Corp., Madison, 
WI) according to the recommendations of the manufacturer. The 
cDNA solution was diluted to 200 txl and 10 I~1 was used for spe- 
cific amplification by PCR. 
PCR and Detection of the Amplified Products.  Primers  for  am- 
plification and probes for detection of hypoxanthine phosphori- 
bosyl transferase  (HPRT), IL-2, -4, -6, -10, and -12, IFN-% g~, 
and pe transcripts have been described (8,  25).  To  amplify and 
detect the  transcript of IL-13,  we  used  the  following primers: 
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Figure  1.  Video densitometric analysis of (A) ge and (B) p{ RT-PCR 
signals as a function of the amount of input cDNA. cDNA obtained from 
spleens isolated from B6 mice immunized for 7 d with GaM8 antiserum 
was serially diluted 1/2 such that each dilution contained 50% of the previ- 
ous dilution of cDNA. After amplification for 33 cycles (ge) and 28 cycles 
(p~) of RT-PCR,  electrophoresis, Southern blotting, hybridization, and 
autoradiography were performed as described in Materials and Methods. 
sense, 5'-ATGGCGCTCTGGGTGACT-3';  antisense, 5'-AAT- 
TGGAGATGTTGGTCAGGG-3';  and  probe,  5'-GGAGTG- 
TGGACCTGGCCG-3'.  PCR was performed with  10  ~1 cDNA 
in 50-1~1 reaction volumes containing 50 mM KC1,  10 mM Tris- 
HC1, pH 9.0, 0.1% Triton X-100, 0.2 rnM for each of the dNTPs, 
1.6 mM MgC12, 400 nM primers, and 1 U  Taq DNA polymerase. 
Digestion-circularization  (DC)-PCR  assays  of genomic DNA 
from spleen cells were performed as described (26). 
The PCR products were separated on  1.2% agarose gels, blot- 
ted onto a nylon membrane (Hybond-N+, Amersham International, 
Birmingham, UK), and hybridized with a fluorescein-labeled probe 
using the ECL-3'  oligolabeling and detection system and Hyper- 
film-ECL (Amersham Corp., Arlington Heights, IL). 
For quantification,  we determined the intensity of hybridizing 
bands with a scanner (Hewlett Packard,  Rockville, MD).  To ac- 
count for variability in starting cDNA concentration and integrity 
among the  samples,  cDNA  from  all samples was  amplified with 
primers for HPRT.  All values obtained for g~ and p~ were nor- 
malized  to  HPRT  expression.  For  quantitative  comparisons  of 
the amounts of g{ and p~ RNA in different samples we generated 
standard  curves  by  serially  diluting  cDNA  samples  of B6  mice 
treated 7 d previously with GaMS. Amplification of ge for 33 cy- 
cles gave a linear correlation between amount of template cDNA 
and g~ product whereas after 28 cycles of amplification pe prod- 
uct correlated directly with the logarithm of input cDNA (Fig. 1). 
Results 
IgE  Production during the  Course of MAIDS  in  IL-4  -l- 
Mice.  Development  of  MAIDS  in  disease-sensitive  B6 
mice  is  associated  with  enhanced  expression  of transcripts 
for the type 2  cytokines,  IL-4 and IL-10,  as well as with in- 
creased transcripts  for the type  1 cytokines,  IL-12,  TNF-ot, 
and  IFN-~/  (14,  27).  In  contrast,  transcripts  for  IL-2  de- 
crease with  time after infection  and progression  of MAIDS 
(14,  27).  To  determine whether the balance  of cytokines is 
Table  1.  B6 Mice Deficient  for IL-4 (B6.IL-4 -I-B6) Produce IgE 
during MAIDS 
Weeks after infection  IL-4 genotype  IgE 
ng/ml 
Experiment 1 
0  +/+  (4)  79  +  36 
-/--(4)  <0.5 
3  +/+  (1)  33 
-/-  (3)  9  +  9 
6  +/+  (1)  448 
-/-  (3)  193  _+  84 
9  +/+  (1)  222 
-/-(3)  431  +  16 
14  +/+  (1)  32 
-/-(4)  91  -+- 43 
Experiment 2 
4  +/+  (3)  294  ----- 47 
--/--(4)  173  +  72 
+/+  (3)  1,578  __  47 
-/-  (3)  751  +  299 
+/+  (3)  711  __-  112 
-/--  (2)  464  ---  272 
12 
B6.IL-4 -/-u6 and control IL-4 +/+ littermates were injected intraperito- 
neally with 0.1  ml LP-BM5 MuLV virus pool. Mice were bled at the 
indicated time points, and serum IgE levels were determined by ELISA. 
Numbers  in  parentheses  indicate  the  number of mice  tested  at  each 
timepoint. Data for lgE levels indicate the mean +  1 SE. 
1653  Morawetz et al. Table 2.  IgE and IgG1 Production afier ln Vivo GaM8 
Immunization 
Days after 
immunization  Mice  IgE  IgG1 
ng/ml  la,g/mI 
0  IL-4  +/+  (8)  33.5 ±  5.5  174 +  59 
IL-4  -/  (10)  <0.5  16 +  4 
BALB/c  (8)  67.5 ±23  135 +  64 
5  IL-4  +/+  (1)  58  211 
IL-4  -/-  (3)  5.3  +  0.3  46 _+ 12 
BALB/c  (1)  159  76 
7  IL-4  +/+  (2)  7,131  ±  2,869  957 +  408 
IL-4  /  (4)  26 +  11.7  223 _+ 80 
BALB/c  (2)  7,814 ±.2,186  14,640  +  3,040 
8  IL-4  +/+  (2)  >10~000  1 t,910 
IL-4  -/-  (3)  22.7 +  11.4  6,303 ±  4,593 
BALB/c  (2)  6,436 +  3,565  ND 
10  IL-4  +/+  (2)  >10,000  >25,000 
IL-4  -/-  (3)  15.5 ±  3.5  5,168 +  2,691 
BALB/c  (2)  1,031  _+ 1  24,325 ±  675 
B6.IL-4  /  129, control IL-4  +/+ littermates, and BALBc mice were in- 
jected subcutaneously with 200 I*1 of GaM8 antiserum. Animals were 
killed on the indicated days, and serum IgE and IgG1 levels were deter- 
mined by ELISA. Numbers in parentheses indicate the number of mice 
in each group. Data for IgE and IgG1 levels indicate the mean +  1 SE. 
a crucial determinant of sensitivity to MAIDS, we have ex- 
amined  the  course  of disease  in  mice  unable  to  produce 
specific cytokines as the  result of gene knockouts. We re- 
ported previously that IL-4 is not required for development 
of MAIDS,  as  B6  IL-4  -/-  mice  were  indistinguishable 
from controls for induction and progression of disease (28). 
As part of this study, we examined the serum Ig isotypes 
in B6.IL-4  /-129  and  normal mice during the  first  12  wk 
after  infection.  Most  noteworthy  was  the  finding  that 
B6.IL-4  -/-129  and  wild-type  mice  had  comparably  high 
levels of serum IgE at 9 wk after infection (346  +  194 and 
817  +  236  ng/ml,  respectively).  This  finding runs  against 
the current understanding of cytokine involvement in iso- 
type switching in the mouse, which holds that switching to 
IgE is  strictly  dependent  on IL-4. To  determine  whether 
these  results  were influenced by residual  129  genes in the 
B6.IL-4  -/-129 congenic mice that may affect penetrance of 
the IL-4  -/- genotype in mice infected with LP-BM5 MuLV 
(28, 29), the study was repeated in IL-4  /  mice generated 
with B6 ES cells,  B6.IL-4  -/-u6 (Table  1). Again, compara- 
ble levels of IgE were detected in the sera of IL-4-deficient 
and Wild-type mice, thus indicating that residual 129 genes in 
the  B6.IL-4  /-129 mice  did  not  influence  IL-4--indepen- 
dent IgE switching in the mouse. 
IgE Production after Treatment  of IL-4  /  Mice  with  GaMS. 
To determine whether comparable expression oflgE in IL- 
4 -/-  and wild-type mice is a situation  unique  to MAIDS, 
we examined other in vivo systems associated with efficient 
induction of IgE. Treatment of mice with GaM8 stimulates 
polyclonal B  cell activation and secretion of large amounts 
of IgE and  IgG1  (30,  31).  The increase  in serum  IgE has 
been shown  to be  dependent  on the  presence  of IL-4, as 
treatment  with  anti-IL-4 mAb  at  the  time  of GaMd  ad- 
ministration  almost completely ablates  IgE secretion with- 
out  affecting  IgG1  production  (6,  9).  Although  previous 
studies  of (B6  ×  129/SvJ)F 2  IL-4  -/-  mice  treated  with 
GaM8  showed that  serum  IgE levels remained  below the 
limits of detection (< 15 ng/ml)  (12), we chose to reexam- 
ine this response using B6.IL-4  -/-t29 mice. 
IL-4 -/-  mice,  control  littermates,  and  BALB/c  mice 
were  injected  subcutaneously  with  GaM8  antiserum,  and 
serum IgE and IgG1 levels were followed for 10 d (Table 2). 
The results showed that IL-4  -/- mice were capable of gen- 
erating an IgE response after stimulation with GaMS, with 
serum levels peaking on day 7  at ~-'30 ng/ml and  thus  at 
least 300-fold lower than wild-type mice which peaked at 
>10,000  ng/ml.  These  findings  confirmed the  suggestion 
that there is an IL-4-independent mechanism for induction 
of IgE  switching  in  the  mouse  but  indicated  that  in  the 
GaM8  system this pathway is much less  efficient than that 
operative  in IL-4-competent mice.  The  IgG1  response  in 
the  B6  IL-4  -/  mice  reached  25%  of the  IgG1  response 
seen in wild-type controls, confirming earlier data showing 
that  switching  to  IgG1  is  not  as  dependent  on  IL-4  as 
switching to IgE (10-12, 32). 
gE and p~ RNA Expression after GaM8 Treatment of lL-4- ~- 
Mice.  IL-4--dependent IgE isotype switching is character- 
ized by induction  of ge followed by pe P,  NA expression. 
We  therefore  wanted  to  determine  whether  the  reduced 
serum IgE levels in IL-4 -/- mice treated with GaM8 were 
due  to  impaired  induction  of g~  and/or  p~  transcripts. 
Semiquantitative  reverse  transcription  (tLT)-PCR  studies 
of RNA from spleens of treated mice revealed that IL-4  -/- 
mice expressed only slightly reduced levels of ge transcripts 
compared with their controls (Fig. 2). The induction of pe 
transcripts,  however, was significantly impaired in IL-4  -/- 
mice (Fig. 2), thus explaining the reduced serum IgE levels 
found  in  these  animals.  Quantification  of the  RT-PCI< 
transcripts  showed  that  while  levels  of g~  transcripts  in 
IL-4-deficient  mice  reached  25  and  50%  of  the  levels 
found in B6 control mice at days 5 and 7, respectively, lev- 
els of pe transcripts in IL-4-deficient mice were undetect- 
able at day 5 and were 200-fold lower than in B6 mice on 
day 7. These findings indicate that although induction ofge 
transcripts can occur quite efficiently in the absence of IL-4, 
switch  recombination  and  translation  of p~  transcripts  are 
more IL-4 dependent than induction of g~ transcripts. 
Contact-mediated  activation  of B  cells  through  CD40- 
CD40L interaction has been shown to induce ge transcripts 
in resting B cells in the absence oflL-4 in vitro (33). GaM8 
immunization leads to activation of anti-goat Ig-specific T 
cells,  which express CD40L and interact with the antigen- 
expressing B  cells  (Finkelman,  F.D.,  unpublished  observa- 
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Figure  2.  Semiquantitative RT-PCR analysis of g~, p~, and cytokine 
expression after in vivo immunization with GaMB antiserum. (A) Unin- 
oculated (control) and treated IL-4-deficient, (B)  wild-type B6,  and  (C) 
BALB/c mice were killed on days 5, 7, and 10 after subcutaneous injec- 
tion of 200  bU  GaM8 antiserum. RT-PCR,  electrophoresis, Southern 
blotting, hybridization, and autoradiography were performed as described 
in  Materials and  Methods. The  experiment shown is representative of 
three independent experiments. 
tion).  This interaction could account for the relatively high 
induction  of g~ levels seen in the IL-4 -/-  mice after injec- 
tion  of GaMB.  Our  data  suggest,  however,  that  the  rate- 
limiting  step  for  lgE  synthesis  is  not  the  induction  of ge 
transcripts  but  rather  switch recombination  resulting in pe 
transcripts  and subsequent  translation  of pe transcripts lead- 
ing to IgE secretion and that IL-4 is involved in the regula- 
tion of these steps. 
Cytokine  Gene Expression in B6.IL-4 -/- Mice Injected  with 
GaMa Antiserum.  In vivo  immunization  with  GaM8  an- 
tibody induces a specific and highly reproducible pattern of 
cytokine  gene expression  during  the course  of the primary 
immune  response  (25).  We  asked whether  this  expression 
pattern,  particularly  IFN-~/expression,  might be altered in 
IL-4 -/-  mice.  IFN-~/  is  known  to  inhibit  IgE  switching, 
and  it  has  been  suggested  to  do  so  by  downregulating  g~ 
transcripts (34, 35), although it does not suppress IgE secre- 
tion  stimulated  by  anti-CD40  plus  IL-4  (36).  RT-PCR 
was used to follow the expression oflFN-~/,  as well as IL-2, 
-4,  -6,  -10,  and  -13,  at  5,  7,  and  10  d  after immunization 
(Fig.  2,  and data not shown).  We found no  significant dif- 
ferences  in  the  kinetics  or  levels  of  expression  of  these 
cytokines  after  treatment  with  GaMS,  although  B6  mice 
(IL-4 -/-  and  controls)  had  slightly  increased  IFN-y  and 
decreased IL-13 levels compared with BALB/c mice. Non- 
productive  IL-4  transcripts  characteristic  of mice  beating 
the disrupted  129  IL-4 gene were constant  throughout  this 
time frame (data not shown). 
Evaluation of the IL-4R~z chain in IL-4Independent Induction 
of  ge and p~. RNA  Expression  and IgE Production in B6.IL-4- l- 
Mice Treated with  GaM8 Antiserum.  The  studies  of  mice 
treated  with  GaMB  antiserum  confirmed  that  there  is  an 
IL-4-independent  mechanism  for  IgE  switching  in  the 
mouse.  It  is  conceivable,  however,  that  the  IL-4-inde- 
pendent  and-dependent  pathways  of IgE  switching  share 
components  of a common signal transduction pathway. It has 
been shown that IL-13 induces human B cells to switch to IgE 
(37).  Furthermore,  there  is  in  vitro  evidence  in  the  mouse 
that IL-13  binds to and signals through an IL-4Re~/IL-13Rot 
heterodimer  (38).  To  assess the  possible  role  of the  IL-4Rot 
chain in the IL-4-independent induction oflgE, B6.IL-4 -/- 129 
mice,  control  littermates,  and  BALB/c  mice  were  treated 
with  a  combination  of anti-IL-4  and  anti-IL-4Re~  mAb 
during  stimulation  with  GaMS.  Treatment  of IL-4-defi- 
cient  mice  with  the  combination  of IL-4  antagonists  did 
not  inhibit  induction  of ge  and  pe  transcripts  or  the  pro- 
duction  of serum  lgE  (Fig.  3,  and  data not  shown).  Day 7 
serum  IgE  levels  in  controls  treated  with  anti-IL-4  and 
anti-lL-4R0¢ were in the range of pretreatment levels, indi- 
cating  that  the  combination  of IL-4  antagonists  efficiently 
blocked  IL-4-dependent  IgE  induction  due  to  GaM8 
treatment  (Fig.  3). 
Studies  of Switch  Recombination  at  the  ~  Locus  in  IL-4 -l- 
Mice.  Expression  of isotypes  other  than  IgM  and  IgD  is 
achieved by recombination  events involving switch regions 
that  are present upstream  of each CH,  except  C8.  This re- 
combination  deletes  the  intervening  CH  genes  from  the 
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Figure 3.  IL-4Rc~  dependence  ofp~ RNA expression and IgE produc- 
tion in GaMS-treated  B6.IL-4  /  129, B6, and BALB/c mice. Mice (three 
mice per group) were injected intraperitoneally  with 4 mg of neutralizing 
anti-lL-4 mAb (11Bll) and 5 mg of IL-4R-blocking mAb (M1) or with 
isotype-matched  control mAb (GLl17).  24 h later the animals were in- 
jected subcutaneously with 200 bU of GaM8 antiserum.  (A) Animals were 
killed  at  day  7  and  serum  IgE  levels were  determined  by ELISA.  (B) 
Splenic levels of pc mRNA were quantitated  by RT-PCR and Southern 
blotting.  Arithmetic  means and standard errors of fold increases over un- 
stimulated levels are shown. 
chromosome.  However,  mechanisms  other than  deletional 
recombination may lead to  expression  of non-IgM  isotypes,  ge 
Alternative  splicing  of  a  long  transcript  which  includes 
VDJ,  Cb~,  and  Ce  or  trans-splicing  between  separate  tran-  HPRT 
scripts encoding VDJ and C~ have been proposed  (39-43). 
Switch recombination  to  St  can be  analyzed by DC-PCR 
studies  of genomic  DNA  (26,  44).  DC-PCR  analysis  of 
splenic  DNA  isolated  from  IL-4-deficient  mice  infected  pe 
with LP-BM5  for 3  wk  or immunized  for 5  and  7  d  with 
GaM8 yielded the predicted  550-bp  PCR  fragment which  HPRT 
hybridized  with  a  specific  Ce  membrane  region  derived 
probe  (Fig.  4).  Thus,  deletional  switch  recombination  can 
occur in the absence of IL-4 and the pe transcripts found in 
the IL-4-deficient mice are most likely to be derived from 
the switched locus. 
Studies  of gE and RNA  Expression  and IgE Production  after 
Infection of lL-4  /  Mice with N.  brasiliensis.  It  was  reported 
B6 
GaM8  LP-BM5 
Day 5  Day 7  3 Weeks  Control 
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Figure 4.  DC-PCR assay of genomic DNA after immunization  with 
GaM8  or infection  with LP-BMS.  B6.IL-4  /  129 and B6 mice were im- 
munized with GaMB and DNA was isolated from spleen cells at days 5 
and 7 after immunization.  B6.IL-4  -/-B6 and B6 mice were infected with 
LP-BM5 and DNA was isolated from spleen cells 3 wk later. DC-PCR, 
electrophoresis,  Southern  blotting,  hybridization,  and  autoradiography 
were performed as described in Materials and Methods.  Switch recombi- 
nation was detected by the presence of a band hybridizing with an oligo- 
nucleotide  from the membrane exon region of Ce. 
that  (B6  X  129/SvJ)F2  IL-4 -/-  mice failed to produce  se- 
rum  IgE  (detection  limit,  15  ng/ml)  on infection  with  N. 
brasiliensis (11,  12).  To examine whether strain background 
might influence IL-4-independent  induction  of IgE in this 
situation,  we  repeated  the  experiment  with  B6.IL-4 -/-129 
mice.  Infection of B6  IL-4 knockout  mice failed to induce 
any detectable serum IgE levels in a primary response or on 
reinfection (detection limit, 25 ng/ml), thus  confirming ear- 
lier studies  (11,  12).  However,  molecular  studies  of these 
mice revealed induction ofge  transcripts  in spleen and me- 
senteric  lymph  node  which  peaked  at  day  7,  while 
switched  pe  transcripts  levels were  below  the  level of de- 
tection in spleen and barely detectable in mesenteric lymph 
node at day  11, when they peaked in the controls.  (Fig. 5). 
To  determine  whether  the  failure  to  progress  from  g~ 
transcriptional  activation to secretion  of IgE in N.  brasilien- 
sis-infected,  IL-4-deflcient  mice  is  modulated  by  IFN-y, 
B6  B6.1L-4  -/-129 
SP  mEN  SP  mEN 
ii  !!71i~]: I ~  ;  %  £ 
Figure 5.  ge and pe expression in N. brasiliensis-infected B6.IL-4 -/-129 
and B6  mice.  Mice (three per group)  were infected  with N.  brasiliensis. 
Mice were killed on days 5, 7, and 11 and spleen and mesenteric lymph- 
nodes harvested for RNA preparation.  RT-PCR, electrophoresis, South- 
ern blotting,  hybridization,  and autoradiography  were performed  as de- 
scribed in Materials and  Methods.  Shown,are day 7 ge transcript  levels 
and day 11 pe transcript levels, which represent their peak levels. 
1656  IL-4-Independent IgE Switching in the Mouse Table 3.  PGE  2 Production during MAIDS and after Immunization  with GaM8 
PGE  2 production after stimulation with 
Mice injected  Time after 
with  injection  Mice  Medium  LPS 
ng/ml  ng/ml 
BM5  0 wk  B6.IL-4  +/+B6  (4)  1.2 _+ 0.7  0.78 +  0.3 
B6.IL-4  -/-B6  (2)  2.3 -+ 1.7  1.76  _+  1 
BM5  3 wk  B6.IL-4  +/+B6  (1)  0.03  78.7 
B6.IL-4  -/-B6  (2)  0.7 -+ 0.2  161.2  +  125.3 
BM5  6 wk  B6.IL-4  +/+B6  (1)  0.3  33.2 
B6.IL-4  /  B6  (3)  2.8 -4- 1.1  37.3  +  12.1 
BM5  9 wk  B6.IL-4  +/+B6  (1)  0.2  150 
B6.IL-4  /  B6  (3)  0.7 +  0.3  66.24 --+ 33.9 
GaM8  5 d  C57BL/6  (2)  0.02  _+ 0.02  0.86  -+ 0.33 
B6.IL-4  /-129  (2)  0.04 +  0.04  1.68  +  0.29 
GaM8  7 d  C57BL/6  (2)  <0.01  2.81  _+ 0.14 
B6.IL-4  /  129  (2)  0.03  +  0.03  4.76  -+ 0.42 
B6.IL-4  /-B6  and control IL-4  +/+ littermates were injected intraperitoneally with 0.1 ml LP-BM5 MuLV virus pool. Animals were killed at the in- 
dicated time points and the spleens isolated. B6.IL-4 -/- 129 and B6 mice were injected subcutaneously with 200 ~1 of GaM8 antiserum. Animals were 
killed on the indicated days, and the spleens isolated. Suspensions of cells prepared from spleen of mice injected with LP-BM5 MuLV or with GaM8 
were stimulated in vitro with LPS. Culture supernatants harvested after 24 h were analyzed for PGE 2 by radioimmunoassay as described in Materials 
and Methods. Numbers for PGE 2 indicate the mean +  1 SE. 
mice were treated with a neutralizing mAb to IFN-',/at the 
time  of primary and  secondary infections.  Serum  IgE  was 
below the limits of detection at days 14 and 21  of the pri- 
mary response, but two of four mice produced IgE (51  ng/ml 
to 243 ng/ml) at days 14 and 21  of the secondary response. 
This indicates that the IL-4-independent pathway for IgE 
switching  is  subject  to  regulation by  IFN-~/  and  suggests 
that  it shares common  elements with  the  IL-4-dependent 
pathway. 
PGE  2 Production during MAIDS and after GaM8 Treatment 
of B6.IL-4 -/-  and Control Mice.  IgE induction in IL-4-defi- 
cient mice after GaM8 immunization and N.  brasiliensis in- 
fection was  very low  or even  absent,  in  sharp  contrast to 
the elevated IgE levels seen during the course of MAIDS. 
Increases in cell proliferation or viability, an increase in the 
percentage of cells undergoing IgE class switching, an increase 
in the average amount of IgE secreted per cell, or a combi- 
nation  of the  above could result in higher IgE levels seen 
during MAIDS. We therefore asked what additional mech- 
anisms might contribute to IgE switching during MAIDS. 
PGE2  and other agents that increase intracellular cAMP 
have been shown to synergize with IL-4 and LPS to induce 
IgE and IgG1 production in normal mice (45-48). They do 
so  by  increasing  the  number  of splenic  B  cells  secreting 
IgE, by promoting class switching of IgM  + B  cells, and by 
synergizing with  IL-4 to induce  ge transcripts. The  possi- 
bility that expression ofPGE 2 might be elevated in MAIDS 
is suggested by the observation that the course of disease is 
delayed in mice treated with meclofenamic acid, an inhibi- 
165.7  Morawetz et al. 
tor of prostaglandin synthase (49).  To address this possibil- 
ity, spleen  cells from  mice  with  MAIDS  were  stimulated 
with LPS  and  the supernatants  tested for PGE  2 (Table 3). 
These studies revealed that significant levels of PGE  2 were 
produced  by  stimulated spleen  cells of both  IL-4  -/-  and 
wild-type mice. In contrast, only low levels of PGE 2 were 
produced by spleen cells of mice treated with GaMS. These 
results  suggest  that  enhanced  expression of prostaglandins 
may contribute to elevated IgE expression in IL-4  -/-  mice 
with MAIDS. 
Discussion 
Both the  mode of 13  cell activation and stimulating cy- 
tokines play important roles in determining the profile of 
secreted Ig isotypes by influencing isotype switching  (50). 
Thus,  13  cells activated by anti-IgD antibodies conjugated 
to  high molecular weight  dextran in the presence  of IL-4 
and IL-5 fail to switch to  IgE, but switching to IgE is in- 
duced  by LPS  and  IL-4.  In  addition,  some  13  cell signals 
may be sufficient to target certain CH genes for switch rear- 
rangement in the absence of cytokines. For example, mem- 
branes from activated T  cells were shown to induce germ- 
line  g~l  transcripts  (32),  and  Sf9  cells expressing CD40L 
induced g~/1 and g~ transcripts in resting splenic 13 cells (33). 
The  systems  used  in  the  current  study to  examine  IgE 
switching in  the  absence  of IL-4  differ markedly and  are 
likely  to  include  aspects  of  T  cell-B  cell  interactions, unique  to  each system, that  affect IgE class switching.  In 
spite  of these  differences,  all  stimuli  investigated  induced 
expression  of g~,  indicating  that  IL-4 is  not  required  for 
this phase of IgE switching in vivo. The latter steps of pe 
transcription and substantial IgE secretion were fully inde- 
pendent of IL-4 only in mice with MAIDS. Thus, pe tran- 
scripts were much reduced in IL-4  -/- mice injected with 
GaM8 antiserum and could barely be detected in mice in- 
fected with  N.  brasiliensis.  In addition,  only low levels  of 
IgE  could  be  detected  in  the  sera  of mice  treated  with 
GaM8  and none  was  detected  in  the  sera of mice after a 
primary infection with N. brasiliensis, suggesting that induc- 
tion and translation ofp~ are more IL-4 dependent than in- 
duction of g~. 
The DC-PClL  analyses demonstrated  that  the  pe  tran- 
scripts detected in IL-4-deficient mice were generated, like 
those  in  wildtype  animals,  by  deletional  recombination. 
This excludes the possibility that IgE expression in IL-4  -/- 
mice can  explained by switching mechanisms fundamen- 
tally different than those used in wild-type mice. 
Although the level of ge transcription has been shown to 
correlate with the level of subsequent IgE synthesis (8, 51), 
transcription per se might be insufficient to direct isotype 
switching (3, 52-54). Our in vivo data show that transcrip- 
tional activation of a germline C H locus does not necessar- 
ily lead to switch recombination and thus supports the no- 
tion  that  these  two  events  are  regulated  separately.  We 
cannot,  however,  exclude  the possibility that  the  level of 
germline  transcription  itself regulates  switch  recombina- 
tion. 
The mechanisms responsible for differing levels of IL-4- 
independent  expression  of ge, pc,  and  IgE in  each of the 
experimental conditions  described  are  not  known.  There 
are extensive data in the literature showing that PGE  2 pro- 
motes isotype switching to  IgE in vitro  (37,  46-48).  The 
finding that splenocytes isolated from BM5-infected mice 
produce PGE  2 in vitro upon stimulation with LPS, whereas 
splenocytes isolated from uninfected control mice or GaMS- 
immunized  mice  do  not,  indicates  that  the  cells  in  the 
former case but not the latter have been primed for PGE  2 
production in vivo. This suggests that PGE  2 may also con- 
tribute  to  the  high  IgE  levels  produced  during  MAIDS. 
Since induction  of g~ transcripts can occur in the absence 
of IL-4, it is  conceivable that  PGE  2 acts in  concert  with 
factors responsible for ge transcription or with other factors 
that facilitate subsequent steps in IgE production, thus lead- 
ing to the high levels of IgE seen during MAIDS. Clearly 
more studies  addressing the  contribution  of PGE  2 to  IgE 
switching need to be done. 
It is  of interest  that  the  IL-4-independent  pathway  of 
IgE induction is subject to regulation by IFN-y, thus pro- 
viding another indication that the IL-4-dependent and -inde- 
pendent pathways of IgE induction have some elements in 
common. 
In MAIDS, B  cells are the major target for infection and 
expression of the LP-BM5  defective virus  (14)  raising the 
possibility that switching to IgE might be activated down- 
stream of the IL-4R by the unique Gag protein encoded by 
this  virus.  To test  this,  we infected  the  CH12.LX  B  cell 
lymphoma with the LP-BM5 defective virus and compared 
the parental and infected cells for expression of ge, pc, and 
IgE. Parental CH12.LX cells  constitutively expressed very 
low levels ofge, infection with LP-BM5 defective virus in- 
duced a 10-fold increase in ge levels (data not shown). The 
defective virus, however, did not induce any detectable pe 
or IgE protein (data not shown). This finding indicates that 
expression of the defective virus in B  cells can augment ge 
expression but that the subsequent steps leading to IgE pro- 
duction  require  additional  signals  which  are not provided 
for by the expression of the defective virus in the B cell. 
A  recent in vitro study showed that CD40-CD40L  in- 
teraction can induce g~ transcripts in mouse B  cells in the 
absence of cytokines, albeit at very low levels (33).  We are 
currently  analyzing  CD40L  expression  in  our  systems to 
evaluate its possible contribution to IL-4-independent IgE 
switching in vivo. Unfortunately,  it will  probably be im- 
possible  to  evaluate  the  importance  of this  interaction  in 
MAIDS,  as  recent  studies  showed  that  mice treated  with 
anti-CD40L  during  the  week  after infection  do  not  de- 
velop disease  (55). 
Human B  cells can be induced to switch to IgE with ei- 
ther  IL-4  or  IL-13  (35,  56),  and  it  has  been  shown  that 
both cytokines signal through the IL-41Koe chain (38).  Mu- 
rine IL-13, however, failed to induce IgE switching in cul- 
tures  of LPS-activated B  cells  and in cultures where puri- 
fied B cells were costimulated by activated Th2 clones (37). 
It  is  conceivable  that,  in  the  mouse,  another  cytokine 
would  signal  through  the  IL-41K~x chain  and  induce  IgE 
switching.  Our studies of immunization with GaM8 in the 
presence  of antibodies  to  IL-4 and  IL-4Rci indicate  that 
signaling  through  the  IL-41Ko~ chain  is  not  involved  in 
IL-4-independent IgE induction in mice; however, an as- 
yet-unidentified signal might trigger this pathway at some 
point  downstream  of the  receptor in  IL-4  -/-  mice,  thus 
leading to IgE switching. 
While  the  studies  reported  here  were  in  progress,  IgE 
production  in  IL-4-deficient mice---although  at  substan- 
tially lower levels than  in  the  controls--was  reported  for 
infection with Plasmodium chabaudi (57) and Leishmania ma- 
jor (58); however, no IgE was found in IL-4-deficient mice 
infected with the nematode Brugia malayi (59). 
In summary, retroviral infection,  infection with a para- 
site, and immunization with GaM8 result in IL-4-indepen- 
dent induction ofgermline •  transcription in vivo, suggest- 
ing  that  the  requirement  for IL-4 in  this  step  of isotype 
switching  in  vivo  can  be  overcome  dependent  on  the 
mode of B cell activation. Whether the signal for induction 
ofgermline transcription is delivered by a cytokine or is cy- 
tokine independent has not been determined. The result of 
in  vitro  studies  showing  that  CD40-CD40L  interaction 
leads to IL-4-independent induction of germline ~ in rest- 
ing  splenic  B  cells  (33)  makes  this  cell  contact-mediated 
signal  a  possible  candidate  for  the  stimulus  to  germline 
transcription in the absence of IL-4 in vivo. 
1658  IL-4-Independent IgE Switching in the Mouse B  cell  activation  leading  to  induction  of germline  tran- 
scription in the absence of lL-4 in vivo does not necessarily 
result  in  switch  recombination  and  IgE  production.  This 
may  indicate  that  these  steps  are  controlled  by  distinct 
mechanisms  in  vivo  and  suggest  that  they  are  more  IL-4 
dependent  than induction  of ge in itself.  The  systems used 
to  examine  the  sequence  of IgE  switching  and  secretion 
are, however, much too different to allow any firm conclu- 
sions. 
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